Distinct roles of enhancer nuclear factor 1 (NF1) sites in plasmacytoma and osteopetrosis induction by Akv1-99 murine leukemia virus

Virology

Volumn 334, Issue 2, 2005, Pages 234-244

  Sørensen, Karina Dalsgaard ^a   Sørensen, Annette Balle ^a   Quintanilla Martinez, Leticia ^b   Kunder, Sandra ^b   Schmidt, Jörg ^b   Pedersen, Finn Skou ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Akv1 99; Murine leukemia virus; Nuclear factor 1; Oncogenesis; Osteopetrosis; Pathogenicity; Plasmacytoma

Indexed keywords

IMMUNOGLOBULIN; NUCLEAR FACTOR I;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CARCINOGENESIS; CARCINOGENICITY; CELL PROLIFERATION; CLONAL VARIATION; CONTROLLED STUDY; ENHANCER REGION; GENE DISRUPTION; GENE REARRANGEMENT; HISTOPATHOLOGY; INBRED STRAIN; MOUSE; MOUSE STRAIN; MURINE LEUKEMIA VIRUS; NONHUMAN; PATHOGENICITY; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; SOUTHERN BLOTTING; VIRUS MUTANT; VIRUS STRAIN; VIRUS VIRULENCE;

MURINAE; MURINE LEUKEMIA VIRUS;

EID: 15244359405     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.039     Document Type: Article

References (59)

1. J.M. Angel, and H.G. Bedigian Expression of murine leukemia viruses in B-cell lymphomas of CWD/Agl mice J. Virol. 52 2 1984 691 694
2. L.G. Byrd, A.H. McDonald, L.G. Gold, and M. Potter Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane J. Immunol. 147 10 1991 3632 3637
3. D. Celander, and W.A. Haseltine Tissue-specific transcription preference as a determinant of cell tropism and leukaemogenic potential of murine retroviruses Nature 312 5990 1984 159 162
4. P.A. Chatis, C.A. Holland, J.E. Silver, T.N. Frederickson, N. Hopkins, and J.W. Hartley A 3′ end fragment encompassing the transcriptional enhancers of nondefective Friend virus confers erythroleukemogenicity on Moloney leukemia virus J. Virol. 52 1 1984 248 254
5. A.Z. Chaudhry, A.D. Vitullo, and R.M. Gronostajski Nuclear factor I (NFI) isoforms differentially activate simple versus complex NFI-responsive promoters J. Biol. Chem. 273 29 1998 18538 18546
6. L. DesGroseillers, and P. Jolicoeur The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential J. Virol. 52 3 1984 945 952
7. S. Ethelberg, B. Hallberg, J. Lovmand, J. Schmidt, A. Luz, T. Grundström, and F.S. Pedersen Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site J. Virol. 71 2 1997 1196 1206
8. S. Ethelberg, J. Lovmand, J. Schmidt, A. Luz, and F.S. Pedersen Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo J. Virol. 71 10 1997 7273 7280
9. S. Ethelberg, B.D. Tzschaschel, A. Luz, S.J. Diaz-Cano, F.S. Pedersen, and J. Schmidt Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer J. Virol. 73 12 1999 10406 10415
10. B. Gao, and G. Kunos Cell type-specific transcriptional activation and suppression of the alpha1B adrenergic receptor gene middle promoter by nuclear factor 1 J. Biol. Chem. 273 48 1998 31784 31787
11. D. Gasparotto, V. De Re, and M. Boiocchi Hepatitis C virus, B-cell proliferation and lymphomas Leuk. Lymphoma 43 4 2002 747 751
12. D.J. Gilbert, P.E. Neumann, B.A. Taylor, N.A. Jenkins, and N.G. Copeland Susceptibility of AKXD recombinant inbred mouse strains to lymphomas J. Virol. 67 4 1993 2083 2090
13. W. Gimbel, J. Schmidt, R. Brack-Werner, A. Luz, P.G. Strauss, V. Erfle, and T. Werner Molecular and pathogenic characterization of the RFB osteoma virus: lack of oncogene and induction of osteoma, osteopetrosis, and lymphoma Virology 224 2 1996 533 538
14. E.A. Golemis, N.A. Speck, and N. Hopkins Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design J. Virol. 64 2 1990 534 542
15. N. Goyal, J. Knox, and R.M. Gronostajski Analysis of multiple forms of nuclear factor I in human and murine cell lines Mol. Cell. Biol. 10 3 1990 1041 1048
16. R.M. Gronostajski Roles of the NFI/CTF gene family in transcription and development Gene 249 1-2 2000 31 45
17. B. Hallberg, and T. Grundström Tissue specific sequence motifs in the enhancer of the leukaemogenic mouse retrovirus SL3-3 Nucleic Acids Res. 16 13 1988 5927 5944
18. B. Hallberg, J. Schmidt, A. Luz, F.S. Pedersen, and T. Grundström SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus J. Virol. 65 8 1991 4177 4181
19. J.W. Hartley, S.K. Chattopadhyay, M.R. Lander, L. Taddesse-Heath, Z. Naghashfar, H.C. Morse, and T.N. Fredrickson Accelerated appearance of multiple B cell lymphoma types in NFS/N mice congenic for ecotropic murine leukemia viruses Lab. Invest. 80 2 2000 159 169
20. R. Hurwitz, J. Hozier, T. LeBien, J. Minowada, K. Gajl-Peczalska, I. Kubonishi, and J. Kersey Characterization of a leukemic cell line of the pre-B phenotype Int. J. Cancer 23 2 1979 174 180
21. N.A. Jenkins, N.G. Copeland, B.A. Taylor, and B.K. Lee Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus J. Virol. 43 1 1982 26 36
22. U. Kruse, and A.E. Sippel The genes for transcription factor nuclear factor I give rise to corresponding splice variants between vertebrate species J. Mol. Biol. 238 5 1994 860 865
23. W.M. Kuehl, and P.L. Bergsagel Multiple myeloma: evolving genetic events and host interactions Nat. Rev., Cancer 2 3 2002 175 187
24. S.C. Lawrenz-Smith, A.C. Massey, D.J. Innes, and C.Y. Thomas Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice J. Virol. 68 8 1994 5174 5183
25. C. Leib-Mösch, J. Schmidt, M. Etzerodt, F. Pedersen, R. Hehlmann, and V. Erfle Oncogenic retrovirus from spontaneous murine osteomas: II. Molecular cloning and genomic characterization Virology 150 1986 96 105
26. J. Lenz, D. Celander, R.L. Crowther, R. Patarca, D.W. Perkins, and W.A. Haseltine Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat Nature 308 5958 1984 467 470
27. Lovmand, J., 1996. PhD thesis. Aarhus University, Denmark.
28. S. Lovmand, N.O. Kjeldgaard, P. Jørgensen, and F.S. Pedersen Enhancer functions in U3 of Akv virus: a role for cooperativity of a tandem repeat unit and its flanking DNA sequences J. Virol. 64 7 1990 3185 3191
29. J. Lovmand, A.B. Sørensen, J. Schmidt, M. Østergaard, A. Luz, and F.S. Pedersen B-Cell lymphoma induction by Akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer J. Virol. 72 7 1998 5745 5756
30. A. Luz, A.B. Murray, and J. Schmidt Osteoma, spontaneous and virus-induced, mouse T.C. Jones U. Mohr R.D. Hunt Monographs on Pathology of Laboratory Animals 1991 ILSI, Springer New York, NY
31. N. Mermod, E.A. O'Neill, T.J. Kelly, and R. Tjian The proline-rich transcriptional activator of CTF/NF-I is distinct from the replication and DNA binding domain Cell 58 4 1989 741 753
32. H.C. Morse III, M.R. Anver, T.N. Fredrickson, D.C. Haines, A.W. Harris, N.L. Harris, E.S. Jaffe, S.C. Kogan, I.C. MacLennan, P.K. Pattengale, and J.M. Ward Bethesda proposals for classification of lymphoid neoplasms in mice Blood 100 1 2002 246 258
33. M.L. Mucenski, B.A. Taylor, N.A. Jenkins, and N.G. Copeland AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas Mol. Cell. Biol. 6 12 1986 4236 4243
34. M.L. Mucenski, B.A. Taylor, N.G. Copeland, and N.A. Jenkins Characterization of somatically acquired ecotropic and mink cell focus-forming viruses in lymphomas of AKXD recombinant inbred mice J. Virol. 61 9 1987 2929 2933
35. M.L. Mucenski, H.G. Bedigian, M.M. Shull, N.G. Copeland, and N.A. Jenkins Comparative molecular genetic analysis of lymphomas from six inbred mouse strains J. Virol. 62 3 1988 839 846
36. G.R. Mundy Mechanisms of bone metastasis Cancer 80 8 Suppl 1997 1546 1556
37. A.B. Murray, J. Schmidt, and A. Luz Osteopetrosis induced by retrovirus, mouse T.C. Jones U. Mohr R.D. Hunt Monographs on Pathology of Laboratory Animals 1991 ILSI, Springer New York, NY 284 291
38. A. Nieves, L.S. Levy, and J. Lenz Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3 J. Virol. 71 2 1997 1213 1219
39. H.S. Olsen, S. Lovmand, J. Lovmand, P. Jørgensen, N.O. Kjeldgaard, and F.S. Pedersen Involvement of nuclear factor I-binding sites in control of Akv virus gene expression J. Virol. 64 9 1990 4152 4161
40. M. Østergaard, L. Pedersen, J. Schmidt, A. Luz, J. Lovmand, V. Erfle, F.S. Pedersen, and P.G. Strauss Mapping of a major osteomagenic determinant of murine leukemia virus RFB-14 to non-long terminal repeat sequences J. Virol. 71 1 1997 645 649
41. M. Potter, and J.S. Wax Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens J. Natl. Cancer Inst. 71 2 1983 391 395
42. M. Potter, and F. Wiener Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations Carcinogenesis 13 10 1992 1681 1697
43. M. Potter, J.W. Hartley, J.S. Wax, and D. Gallahan Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice J. Exp. Med. 160 2 1984 435 440
44. G.D. Roodman Mechanisms of bone lesions in multiple myeloma and lymphoma Cancer 80 8 1997 S1557 S1563
45. + B-cell populations of IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKV Fv-1b mice Cancer Res. 53 1993 2147 2153
46. J. Schmidt, V. Erfle, F.S. Pedersen, H. Rohmer, H. Schetters, K.H. Marquart, and A. Luz Oncogenic retrovirus from spontaneous murine osteomas: I. Isolation and biological characterization J. Gen. Virol. 65 Pt. 12 1984 2237 2248
47. J. Schmidt, A. Luz, and V. Erfle Endogenous murine leukemia viruses: frequency of radiation-activation and novel pathogenic effects of viral isolates Leuk. Res. 12 5 1988 393 403
48. J. Schmidt, V. Krump-Konvalinkova, A. Luz, R. Goralczyk, G. Snell, S. Wendel, S. Dorn, L. Pedersen, P.G. Strauss, and V. Erfle Akv murine leukemia virus enhances bone tumorigenesis in hMT-c-fos-LTR transgenic mice Virology 206 1 1995 85 92
49. J. Schmidt, K. Lumniczky, B.D. Tzschaschel, H.L. Guenther, A. Luz, S. Riemann, W. Gimbel, V. Erfle, and R.G. Erben Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus. Increase in bone mass precedes lymphomagenesis Am. J. Pathol. 155 2 1999 557 570
50. A.B. Sørensen, M. Duch, P. Jørgensen, and F.S. Pedersen Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method J. Virol. 67 12 1993 7118 7124
51. N.A. Speck, B. Renjifo, E. Golemis, T.N. Fredrickson, J.W. Hartley, and N. Hopkins Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity Genes Dev. 4 2 1990 233 242
52. C. Speth, A. Luz, P.G. Strauss, S. Wendel, R. Zeidler, S. Dorn, V. Erfle, G. Brem, M. Lipp, and J. Schmidt Akv murine leukemia virus enhances lymphomagenesis in myc-kappa transgenic and in wild-type mice Virology 206 1 1995 93 99
53. A.M. Stall, M.C. Farinas, D.M. Tarlinton, P.A. Lalor, L.A. Herzenberg, and S. Strober Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals Proc. Natl. Acad. Sci. U.S.A. 85 19 1988 7312 7316
54. H. Sudo, H.A. Kodama, Y. Amagai, S. Yamamoto, and S. Kasai In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria J. Cell Biol. 96 1 1983 191 198
55. + Ly-1 B clones of (NZB x NZW)F1 mice EMBO J. 7 12 1988 3705 3710
56. W.K. Weng, and S. Levy Hepatitis C virus (HCV) and lymphomagenesis Leuk. Lymphoma 44 7 2003 1113 1120
57. A.K. Werenskiold, U. Rossler, M. Lowel, J. Schmidt, K. Heermeier, M.T. Spanner, and P.G. Strauss Bone matrix deposition of T1, a homologue of interleukin 1 receptors Cell Growth Differ. 6 2 1995 171 177
58. M. Whyte Sclerosing bone dysplasias Primer on the metabolic bone diseases and disorders of mineral metabolism 3rd ed. 1996 Lippincott-Raven Philadelphia, PA 363 387
59. Y. Yamada, H. Matsushiro, M.S. Ogawa, K. Okamoto, Y. Nakakuki, S. Toyokuni, M. Fukumoto, and H. Hiai Genetic predisposition to pre-B lymphomas in SL/Kh strain mice Cancer Res. 54 2 1994 403 407